Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| SABS | SAB BIOTHERAPEUTICS INC | $263.80M | 76,464,094 | 57.16% | 42.84% | Net Buying | |||
| HBM | HUDBAY MINERALS INC | $8.65B | 397,196,119 | 74.59% | 0.00% | ||||
| ALT | ALTIMMUNE INC | $581.48M | 194,474,154 | 35.67% | 32.64% | Net Buying | |||
| IDYA | IDEAYA BIOSCIENCES INC | $3.18B | 87,860,920 | 92.57% | 7.43% | Net Buying | Net Buying | ||
| KLRS | KALARIS THERAPEUTICS INC | $79.47M | 23,792,278 | 5.85% | 94.15% | Net Buying | Net Buying | ||
| SPTX | SEAPORT THERAPEUTICS INC | $1.07B | 53,530,550 | 0.00% | 74.84% | Net Buying | Net Buying | ||
| EROC | EROCK INC | N/A | 48,124,888 | 0.00% | 100.00% | ||||
| MDXG | MIMEDX GROUP INC | $649.40M | 148,945,731 | 48.14% | 51.86% | Net Buying | Net Buying | ||
| FDX | FEDEX CORP | $73.96B | 236,581,188 | 79.13% | 9.64% | Net Buying | Net Buying | ||
| KEEL | KEEL INFRASTRUCTURE CORP | $2.26B | 603,828,651 | 42.26% | 0.36% | Net Selling | Net Selling | ||
| AZTA | AZENTA INC | $1.33B | 46,092,804 | 70.83% | 29.17% | Net Buying | Net Buying | ||
| SPHR | SPHERE ENTERTAINMENT CO | $5.06B | 35,792,203 | 95.49% | 4.51% | Net Selling | |||
| FSV | FIRSTSERVICE CORP | $6.48B | 45,341,000 | 70.07% | 0.00% | ||||
| ZLAB | ZAI LAB LTD | $2.09B | 1,123,548,580 | 2.51% | 1.78% | Net Buying | Net Buying | ||
| TNGX | TANGO THERAPEUTICS INC | $3.85B | 144,647,982 | 68.39% | 31.61% | Net Selling | Net Buying | ||
| AVAV | AEROVIRONMENT INC | $7.91B | 50,608,030 | 40.13% | 59.87% | Net Selling | Net Selling | ||
| GHRS | GH RESEARCH PLC | $1.73B | 62,029,395 | 76.01% | 23.99% | ||||
| ONC | BEONE MEDICINES LTD | $36.78B | 1,445,262,342 | 2.41% | 31.88% | Net Selling | Net Selling | ||
| PPTA | PERPETUA RESOURCES CORP | $2.18B | 125,094,503 | 59.66% | 40.34% | Net Selling | |||
| EZPW | EZCORP INC | $1.85B | 61,535,978 | 85.93% | 14.07% | Net Buying | Net Selling | ||
| ADUR | ADURO CLEAN TECHNOLOGIES INC | $436.92M | 33,635,303 | 2.24% | 0.00% | ||||
| KGC | KINROSS GOLD CORP | $28.07B | 1,194,109,463 | 60.00% | 0.00% | ||||
| STTK | SHATTUCK LABS INC | $522.96M | 76,680,517 | 73.12% | 19.69% | Net Buying | Net Buying | ||
| AHCO | ADAPTHEALTH CORP | $1.53B | 136,054,152 | 45.46% | 54.54% | Net Buying | Net Selling | ||
| AMBA | AMBARELLA INC | $3.03B | 43,868,185 | 71.50% | 28.50% | Net Selling | Net Selling | ||
| AVTX | AVALO THERAPEUTICS INC | $1.03B | 52,565,572 | 27.61% | 72.39% | Net Selling | Net Selling | ||
| ANRO | ALTO NEUROSCIENCE INC | $962.28M | 35,093,940 | 76.45% | 18.01% | Net Selling | |||
| TRVI | TREVI THERAPEUTICS INC | $2.62B | 141,979,708 | 43.91% | 56.09% | Net Buying | |||
| DNLI | DENALI THERAPEUTICS INC | $3.82B | 158,709,737 | 62.37% | 37.63% | Net Selling | |||
| ITRG | INTEGRA RESOURCES CORP | $422.72M | 202,257,000 | 32.81% | 0.00% | ||||
| EQ | EQUILLIUM INC | $146.69M | 63,226,556 | 64.05% | 22.25% | Net Selling | Net Selling | ||
| ALM | ALMONTY INDUSTRIES INC | $3.21B | 262,776,228 | 36.74% | 0.00% | ||||
| DSGN | DESIGN THERAPEUTICS INC | $741.36M | 62,456,974 | 48.28% | 51.72% | Net Selling | |||
| NYXH | NYXOAH SA | $61.53M | 43,026,460 | 8.36% | 0.00% | ||||
| ASST | STRIVE INC | $875.53M | 73,082,631 | 14.33% | 85.67% | Net Buying | |||
| CLYM | CLIMB BIO INC | $703.73M | 57,260,523 | 56.39% | 11.04% | Net Buying | Net Selling | ||
| ONIT | ONITY GROUP INC | $340.57M | 8,432,137 | 3.18% | 96.82% | Net Selling | Net Selling | ||
| ALLO | ALLOGENE THERAPEUTICS INC | $572.96M | 345,154,561 | 53.35% | 22.59% | Net Selling | |||
| MANE | VERADERMICS INC | $4.66B | 41,778,687 | 62.15% | 15.06% | Net Buying | |||
| LTRX | LANTRONIX INC | $212.22M | 39,816,930 | 9.82% | 90.18% | Net Selling | Net Selling | ||
| CING | CINGULATE INC | $60.14M | 13,276,022 | 8.95% | 32.96% | Net Buying | |||
| PTEN | PATTERSON UTI ENERGY INC | $3.48B | 379,617,653 | 83.60% | 16.40% | Net Selling | Net Selling | ||
| MGPI | MGP INGREDIENTS INC | $399.86M | 21,371,237 | 25.56% | 74.44% | Net Selling | Net Selling | ||
| TTAN | SERVICETITAN INC | $7.48B | 95,397,579 | 47.66% | 52.34% | Net Selling | Net Selling | ||
| CPS | COOPER-STANDARD HOLDINGS INC | $525.73M | 17,755,284 | 64.85% | 19.96% | Net Selling | Net Selling | ||
| EVEX | EVE HOLDING INC | $853.35M | 348,304,584 | 5.13% | 94.87% | Net Buying | |||
| VIA | VIA TRANSPORTATION INC | $1.67B | 81,295,871 | 47.19% | 34.92% | Net Selling | Net Buying | ||
| CADL | CANDEL THERAPEUTICS INC | $709.26M | 73,270,239 | 59.27% | 24.02% | Net Buying | Net Selling | ||
| BTGO | BITGO HOLDINGS INC | $576.32M | 115,959,409 | 30.56% | 12.83% | Net Selling | Net Selling | ||
| PEPG | PEPGEN INC | $126.58M | 69,169,215 | 80.68% | 9.74% | Net Buying | Net Selling | ||
| WHK | WHITEHAWK MINERALS CORP | N/A | 25,971,579 | 0.00% | 27.29% | ||||
| GENB | GENERATE BIOMEDICINES INC | $1.68B | 128,192,484 | 57.21% | 42.79% | Net Buying | |||
| CLS | CELESTICA INC | $40.27B | 114,982,086 | 65.67% | 0.99% | Net Selling | Net Selling | ||
| ABVX | ABIVAX SA | $9.81B | 78,958,563 | 63.37% | 0.00% | ||||
| TYRA | TYRA BIOSCIENCES INC | $1.84B | 59,470,381 | 65.84% | 34.16% | Net Selling | |||
| AKTS | AKTIS ONCOLOGY INC | $1.23B | 53,404,618 | 52.35% | 47.65% | Net Buying | Net Buying | ||
| LTM | LATAM AIRLINES GROUP SA | $30.74B | 574,215,983,709 | 0.01% | 0.00% | ||||
| RAPP | RAPPORT THERAPEUTICS INC | $2.01B | 47,826,929 | 77.59% | 22.41% | Net Selling | Net Selling | ||
| B | BARRICK MINING CORP | $61.49B | 1,676,000,000 | 61.92% | 0.00% | ||||
| SLDB | SOLID BIOSCIENCES INC | $784.64M | 98,449,606 | 60.22% | 39.78% | Net Selling | |||
| ALXO | ALX ONCOLOGY HOLDINGS INC | $267.78M | 134,562,917 | 70.06% | 10.95% | Net Buying | Net Selling | ||
| CX | CEMEX SAB DE CV | $17.41B | 14,507,429,244 | 3.51% | 1.82% | Net Selling | Net Selling | ||
| CGEM | CULLINAN THERAPEUTICS INC | $1.07B | 61,458,046 | 57.24% | 42.76% | Net Buying | Net Selling | ||
| QNCX | QUINCE THERAPEUTICS INC | $15.79M | 815,037 | 25.69% | 74.31% | Net Selling | |||
| CATX | PERSPECTIVE THERAPEUTICS INC | $327.31M | 114,046,197 | 41.47% | 58.53% | Net Buying | |||
| PBLS | PARABILIS MEDICINES INC | N/A | 118,750,719 | 0.00% | 6.61% | Net Buying | Net Buying | ||
| PAAS | PAN AMERICAN SILVER CORP | $18.22B | 421,424,000 | 51.40% | 0.00% | ||||
| DEFT | DEFI TECHNOLOGIES INC | $165.58M | 387,777,239 | 7.17% | 0.00% | ||||
| KLRA | KAILERA THERAPEUTICS INC | $2.17B | 129,565,608 | 0.00% | 85.31% | Net Buying | Net Buying | ||
| EXE | EXPAND ENERGY CORP | $21.18B | 239,228,849 | 90.19% | 9.81% | Net Buying | Net Buying | ||
| OLMA | OLEMA PHARMACEUTICALS INC | $1.01B | 87,347,471 | 79.99% | 20.01% | Net Selling | Net Selling | ||
| ABCL | ABCELLERA BIOLOGICS INC | $1.62B | 305,375,393 | 40.70% | 44.12% | Net Buying | Net Buying | ||
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUTICS INC | $688.12M | 80,107,104 | 62.76% | 37.24% | Net Buying | Net Selling | ||
| NSLR | NEOSTELLAR CAPITAL CORP | $265.13M | 26,070,208 | 20.57% | 16.91% | Net Selling | Net Selling | ||
| RLMD | RELMADA THERAPEUTICS INC | $548.58M | 104,890,223 | 79.76% | 3.37% | Net Buying | |||
| ARTV | ARTIVA BIOTHERAPEUTICS INC | $260.27M | 24,716,672 | 47.68% | 52.32% | Net Buying | Net Buying | ||
| ZBIO | ZENAS BIOPHARMA INC | $2.04B | 63,133,377 | 74.49% | 25.51% | Net Buying | Net Buying | ||
| BEAT | HEARTBEAM INC | $29.25M | 55,506,835 | 9.27% | 19.39% | Net Buying | |||
| SPRB | SPRUCE BIOSCIENCES INC | $114.49M | 2,752,278 | 3.89% | 96.11% | Net Selling | Net Buying | ||
| GLXY | GALAXY DIGITAL INC | $8.16B | 389,900,100 | 33.54% | 1.50% | Net Selling | Net Selling | ||
| TFPM | TRIPLE FLAG PRECIOUS METALS CORP | $5.90B | 206,603,912 | 84.74% | 0.00% | ||||
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $1.38B | 73,615,396 | 77.11% | 22.89% | Net Selling | Net Selling | ||
| KPTI | KARYOPHARM THERAPEUTICS INC | $160.68M | 22,662,943 | 33.55% | 66.45% | Net Selling | Net Selling | ||
| AGI | ALAMOS GOLD INC | $12.09B | 419,860,744 | 56.82% | 0.00% | ||||
| CHRD | CHORD ENERGY CORP | $7.25B | 56,299,183 | 98.37% | 1.63% | Net Selling | Net Selling | ||
| FHTX | FOGHORN THERAPEUTICS INC | $301.20M | 58,713,922 | 75.69% | 14.46% | ||||
| OFIX | ORTHOFIX MEDICAL INC | $495.57M | 40,421,652 | 70.58% | 29.42% | Net Buying | Net Selling | ||
| OBIO | ORCHESTRA BIOMED HOLDINGS INC | $231.14M | 59,880,715 | 36.71% | 63.29% | Net Buying | Net Selling | ||
| CAMP | CAMP4 THERAPEUTICS CORP | $177.59M | 51,925,800 | 60.47% | 39.53% | Net Buying | |||
| ODTX | ODYSSEY THERAPEUTICS INC | $885.22M | 48,031,320 | 0.00% | 25.85% | Net Buying | Net Buying | ||
| ANL | ADLAI NORTYE LTD | $507.10M | 120,000,803 | 9.66% | 14.54% | Net Selling | Net Selling | ||
| SAIL | SAILPOINT INC | $8.95B | 567,182,997 | 52.81% | 47.19% | Net Selling | Net Selling | ||
| NOK | NOKIA CORP | $51.28B | 5,742,239,696 | 18.70% | 0.00% | ||||
| ZURA | ZURA BIO LTD | $526.29M | 94,997,710 | 53.86% | 46.14% | Net Buying | |||
| TSM | TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | $2.03T | 25,932,370,000 | 2.97% | 6.66% | Net Selling | Net Selling | ||
| MDA | MDA SPACE LTD | $3.78B | 126,321,001 | 64.23% | 0.00% | ||||
| AVLN | AVALYN PHARMA INC | $1.23B | 44,333,095 | 0.00% | 29.18% | Net Buying | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.